Gilder Gagnon Howe & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-57,031
| Closed | -$13.2M | – | 253 |
|
|
2024
Q2 | $13.2M | Sell |
57,031
-2,910
| -5% | -$675K | 0.17% | 103 |
|
|
2024
Q1 | $12.9M | Sell |
59,941
-8,538
| -12% | -$1.84M | 0.16% | 109 |
|
|
2023
Q4 | $17.7M | Buy |
68,479
+901
| +1% | +$233K | 0.24% | 94 |
|
|
2023
Q3 | $17.4M | Sell |
67,578
-12,719
| -16% | -$3.27M | 0.26% | 81 |
|
|
2023
Q2 | $22.9M | Buy |
80,297
+25,885
| +48% | +$7.37M | 0.31% | 75 |
|
|
2023
Q1 | $15.1M | Sell |
54,412
-2,129
| -4% | -$592K | 0.25% | 87 |
|
|
2022
Q4 | $15.7M | Buy |
+56,541
| New | +$15.7M | 0.29% | 87 |
|
|
2021
Q3 | – | Sell |
-2,794
| Closed | -$967K | – | 425 |
|
|
2021
Q2 | $967K | Sell |
2,794
-3,634
| -57% | -$1.26M | ﹤0.01% | 331 |
|
|
2021
Q1 | $1.8M | Buy |
+6,428
| New | +$1.8M | 0.01% | 281 |
|
|
2016
Q4 | – | Sell |
-177
| Closed | -$55K | – | 267 |
|
|
2016
Q3 | $55K | Buy |
+177
| New | +$55K | ﹤0.01% | 256 |
|
|
2015
Q3 | – | Sell |
-1,062
| Closed | -$429K | – | 260 |
|
|
2015
Q2 | $429K | Sell |
1,062
-2
| -0.2% | -$808 | 0.01% | 234 |
|
|
2015
Q1 | $449K | Buy |
1,064
+982
| +1,198% | +$414K | 0.01% | 224 |
|
|
2014
Q4 | $28K | Buy |
+82
| New | +$28K | ﹤0.01% | 266 |
|